Suchergebnisse - "Criscuolo, Clelia"

PubPharm (3)

1

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma : Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

enthalten in: Hematological oncology | 2022

von Bruzzese, A. | Derudas, D. | Galli, M. | +57

2

Immune reactivity during COVID-19 : Implications for treatment

enthalten in: Immunology letters | 2021

von Napoli, C. | Benincasa, G. | Criscuolo, C. | +3

3

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma : Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

enthalten in: Haematologica | 2021

von Gentile, M. | Specchia, G. | Derudas, D. | +53

1
[1]